LINC00665: A Potential Drug Target and Biomarker (G100506930)

Target Name: LINC00665

NCBI ID: G100506930

LINC00665

Other Name(s): long intergenic non-protein coding RNA 665 | AC092296.1 | CIP2A-BP | Long intergenic non-protein coding RNA 665, transcript variant 1

LINC00665: A Potential Drug Target and Biomarker

LINC00665 is a long non-coding RNA (lncRNA) that has been identified as a potential drug target and biomarker. It is located on chromosome 6 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. LINC00665 has also been shown to be involved in the development and progression of various diseases, including cancer. As a result, LINC00665 has become a focus of interest for researchers looking for new treatments for these diseases.

Drug Target Potential

LINC00665 has been shown to have potential as a drug target by various experiments. One study published in the journal PLoS found that LINC00665 was highly expressed in human cancer tissues and was associated with cancer progression. The authors also found that inhibiting LINC00665 reduced the growth of cancer cells in cell culture and animal models.

Another study published in the journal Oncogene found that LINC00665 was involved in the development of brain tumors. The authors showed that LINC00665 was highly expressed in human brain tumors and that inhibiting LINC00665 reduced the growth of brain tumor cells in cell culture and animal models.

Biomarker Potential

LINC00665 has also been shown to have potential as a biomarker for various diseases. One study published in the journal Diabetes found that LINC00665 was highly expressed in the blood samples of individuals with type 2 diabetes and was associated with increased risk of complications. The authors also found that LINC00665 was downregulated in the blood samples of individuals with type 2 diabetes and that increasing LINC00665 levels was associated with improved insulin sensitivity and reduced blood glucose levels.

Another study published in the journal Cancer found that LINC00665 was highly expressed in various cancer tissues and was associated with cancer progression. The authors also found that LINC00665 was downregulated in various cancer tissues and that increasing LINC00665 levels was associated with cancer growth and metastasis.

Overall, LINC00665 is a promising drug target and biomarker that has the potential to be used in the treatment of various diseases. Further research is needed to fully understand the role of LINC00665 in disease and to develop safe and effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 665

The "LINC00665 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00665 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets